URANIA THERAPEUTICS
Urania Therapeutics company is developing a unique SBDD platform for the generation of new readthrough compounds with high potential in cancer and monogenic disorders.
URANIA THERAPEUTICS
Industry:
Biotechnology Pharmaceutical
Founded:
2015-01-01
Address:
Strasbourg, Alsace, France
Country:
France
Website Url:
http://www.uraniatx.com
Total Employee:
11+
Status:
Active
Total Funding:
5.23 M EUR
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Apple Mobile Web Clips Icon WordPress SSL By Default IPv6 ReCAPTCHA Apache Wordpress Plugins
Similar Organizations
Aratana Therapeutics
Aratana Therapeutics develops innovative therapies for the animal health industry.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Versameb
Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs.
Current Employees Featured
Founder
Investors List
Bpifrance
Bpifrance investment in Seed Round - Urania Therapeutics
AdBio partners
AdBio partners investment in Seed Round - Urania Therapeutics
Cap Innov'Est
Cap Innov'Est investment in Seed Round - Urania Therapeutics
Official Site Inspections
http://www.uraniatx.com Semrush global rank: 13.31 M Semrush visits lastest month: 78
- Host name: webacc0.sd5.ghst.net
- IP address: 155.133.138.2
- Location: Poland
- Latitude: 52.2394
- Longitude: 21.0362
- Timezone: Europe/Warsaw
More informations about "Urania Therapeutics"
Urania Therapeutics – Developing treatments for …
2021/12/01. In collaboration with the Yusupov lab at IGBMC, Urania publishes today an article in Nature entitled "Accuracy mechanism of eukaryotic ribosome translocation" describing the 3.2-Å-resolution X-ray structure of the eukaryotic …See details»
Urania Therapeutics - Crunchbase Company Profile & Funding
Readthrough compound development: Urania Therapeutics is focused on developing compounds that enable the readthrough of nonsense mutations, which are a cause of many genetic …See details»
Urania Therapeutics 2025 Company Profile: Valuation, …
Urania Therapeutics General Information Description. Operator of a biopharmaceutical company intended to specialize in the identification and …See details»
Urania Therapeutics closes a 3.5M initial seed round
Www.uraniatx.com Media contacts and analysts Andrew Lloyd & Associates Jo Reeder – Juliette dos Santos [email protected] - [email protected] Tel : +44 1273 675 100 @ALA_Group . Title: …See details»
Urania Therapeutics - Craft
Urania Therapeutics (formerly RiboStruct) is a company developing treatments for genetic diseases caused by mutations. It creates readthrough compounds targeting the human …See details»
Board of Directors – Urania Therapeutics
2021/12/01. In collaboration with the Yusupov lab at IGBMC, Urania publishes today an article in Nature entitled "Accuracy mechanism of eukaryotic ribosome translocation" describing the 3.2-Å-resolution X-ray structure of the eukaryotic …See details»
Urania Therapeutics - VentureRadar
"Urania Therapeutics, a spin-off from IGBMC in partnership with NovAliX, an integrated drug discovery company, is pursuing a unique structure-based drug design approach targeting the …See details»
Contact – Urania Therapeutics
2021/12/01. In collaboration with the Yusupov lab at IGBMC, Urania publishes today an article in Nature entitled "Accuracy mechanism of eukaryotic ribosome translocation" describing the 3.2 …See details»
Urania Therapeutics - Golden
Golden has been acquired by ComplyAdvantage. Read about it here . Urania Therapeutics. Urania Therapeutics is a France-based company.See details»
Urania Therapeutics lève 3,5 millions d’euros en amorçage
Www.uraniatx.com . Contact presse et analystes Andrew Lloyd & Associates Céline Gonzalez – Juliette dos Santos [email protected] – [email protected] Tel : +33 1 56 54 07 00 @ALA_Group …See details»
Urania Therapeutics - Overview, News & Similar companies
Www.uraniatx.com. Revenue <$5 Million. Industry Business Services General Business Services . Recent News & Media. No recent news or media. Overview ; Who is Urania Therapeutics. …See details»
Truth About Urania Therapeutics. Is Urania Therapeutics the Right …
Read reviews of Urania Therapeutics. Write and share your personal story. Your experience will help others make the right buying decision.See details»
Urania Therapeutics - VentureRadar
Salzman Group USA n/a Serving as both a boutique service organization, as well as an innovative biotech company, SG carries out comprehensive drug development including hit selection, …See details»
Urania Therapeutics benefits from €1.7M Deeptech financing from ...
Jan 16, 2020 Strasbourg, France, January 14, 2020 – Urania Therapeutics announces today that it will benefit from €1.7 million ($1.9M) Deeptech financing from Bpifrance in addition to its …See details»
Organisation vs. Organization: What’s the Difference?
The US nuclear base at Incirlik is a key part of western defences; were Turkey to leave the organisation its loss would be a serious blow. –The Telegraph Gianforte said the $50,000 …See details»
Urantia Organizations - Urantia Artisans
The Urantia Society of Greater New York (USGNY) is a local, New York area based organization with a global focus and outreach effort. In addition to numerous local dissemination projects, …See details»
Urania Therapeutics | VentureRadar
Website: http://www.uraniatx.com/ Develops therapeutic solutions for genetic diseases caused by nonsense mutations, using a protein repair therapy approach to ...See details»
Urania Therapeutics benefits from 1.7M Deeptech financing from …
Www.uraniatx.com Media contacts and analysts Andrew Lloyd & Associates Jo Reeder – Juliette dos Santos [email protected] - [email protected] Tel: +44 1273 675 100 @ALA_Group . Title: …See details»
Science – Urania Therapeutics
Urania Therapeutics provides a therapeutic solution for the treatment of genetic diseases caused by. nonsense mutations (10-15% of cases), which introduce a STOP codon into the coding …See details»
History – Urania Therapeutics
2021/12/01. In collaboration with the Yusupov lab at IGBMC, Urania publishes today an article in Nature entitled "Accuracy mechanism of eukaryotic ribosome translocation" describing the 3.2 …See details»